期刊文献+

乳腺癌组织中CD133和VEGF的表达及意义 被引量:5

Expression and significance of CD133 and VEGF in breast cancer
原文传递
导出
摘要 目的研究CD133及血管内皮生长因子(VEGF)在乳腺癌组织中的表达及其意义。方法采用免疫组织化学方法检测109例乳腺癌组织中的CD133及VEGF的表达,并对结果进行分析。结果乳腺癌组织中CD133和VEGF蛋白的表达率分别是46.8%(51/109)和84.4%(92/109),其阳性表达率随肿瘤病理级别的升高而明显增加(P<0.05)。乳腺癌Basal-like亚群中CD133蛋白的阳性率表达高达69.2%,高于其他亚群(P<0.05)。CD133与VEGF表达密切相关(P<0.01)。结论CD133与VEGF蛋白表达可能与乳腺癌肿瘤干细胞生长有关。 Objective To investigate the expression and significance of CD133 and vascular endothelial growth factor(VEGF)in breast cancer.Methods CD133 and VEGF protein expressions were studied by immunohistochemistry in 109 cases with breast cancer.Results The expression rates of CD133 and VEGF proteins in the cancer tissues were 46.8%(51/109)and 84.4%(92/109),respectively,which increased as the tumor grade elevated(P〈0.05).The positive expression rate of CD133 was as high as 69.2% in Basal-like subtype of breast cancer,which was higher than that in the other subtypes(P〈0.05).The expression of CD133 was closely correlated with that of VEGF(P〈0.01).Conclusion CD133 and VEGF proteins play important roles in the progression of breast cancer.
出处 《江苏医药》 CAS CSCD 北大核心 2010年第1期2-4,共3页 Jiangsu Medical Journal
基金 国家自然科学基金(30672390) 苏州大学博士基金(14134803)
关键词 血管内皮生长因子 CD133 乳腺癌 Vascular endothelial growth factor CD133 Breast cancer
  • 相关文献

参考文献10

  • 1Gil J, Stemhalska A, Pesz KA, et al. Cancer stem cells: the theory and perspectives in cancer therapy[J]. J Appl Genet, 2008,49(2) : 193-199.
  • 2Toren A, Bielorai B, Jacob-Hirseh J,et al. CD133-positive hematopoietic stem cell "sternness" genes contain many genes mutated or abnormally expressed in leukemia [J]. Stem Cells, 2005,23 (8) : 1142-1153.
  • 3谢芳,邓敏,邓海贞,任苏勤,蒋栋毅,张学光.人脑星形细胞瘤组织中低氧诱导因子1α与p53的生物学意义[J].江苏医药,2007,33(1):3-5. 被引量:3
  • 4谢芳,邓海贞,顾永平,任苏勤,蒋栋毅,吴德明.星形细胞瘤组织中缺氧诱导因子-1α、VEGF、iNOs的表达及其与MVD的关系[J].临床与实验病理学杂志,2006,22(4):458-460. 被引量:2
  • 5Tavassoeli FA, Devilee P. Pathology and genetics tumours of the breast and female genital organs[M], Lyom IARC Press, 2003 : 10-20.
  • 6Millikan C, Newman B, Tse CK, et al. Epidemiology of basal- like breast cancer[J]. Breast Cancer Res Treat, 2008, 109 (1):123-139.
  • 7许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1379
  • 8Hilbe W, Dirnhofer S, Oberwasserlechner F, et al. CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer[J]. J Clin Pathol, 2004,57(9) :965-969.
  • 9Zhang M,Song T, Yang L, et al. Nestin and CD133 : valuable stern cell-specific markers for determining clinical outcome of glioma patients[J]. J Exp Clin Cancer Res, 2008,27 (1) : 85-92.
  • 10Xu J, Xu HY, Zhang Q, et al. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma[J].Mol Cancer Res,2007,5(6) :605-614.

二级参考文献23

  • 1许春梅,董卫国,余保平,罗和生,于皆平.低氧诱导因子-1α及诱导型一氧化氮合酶在炎症性肠病中的表达[J].第四军医大学学报,2004,25(17):1558-1561. 被引量:4
  • 2许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1379
  • 3赵彤,朱梅刚,黄宗义,张亚历,张素娟,李梅芳.肺癌癌基因蛋白产物同步检测的对比分析[J].癌症,1995,14(1):13-15. 被引量:54
  • 4谷化平,冯和平,徐志勇,苏红.免疫组化在恶性黑色素瘤诊断中的作用[J].中国肿瘤临床,1996,23(8):599-600. 被引量:4
  • 5Vartanian R K,Weidner N.Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia:correlation with Gleason's score,microvessel density,and epithelial cell proliferation[J].Lab Invest,1995,73(6):844-850.
  • 6Unruh A,Ressel A,Mohamed H G,et al.The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy[J].Oncogene,2003,22(21):3213-3220.
  • 7Bachtiary B,Schindl M,Potter R,et al.Overexpression of hypoxia-inducible factor 1 alpha indicates diminished response to radio-therapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer[J].Clin Cancer Res,2003,9(6):2234-2240.
  • 8Semenza G L.HIF-1 and human disease:one highly involved factor[J].Genes Develop,2000,14:1983-1991.
  • 9Jung F,Palmer L A,Zhou N,et al.Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes[J].Circ Res,2000,86(31):319-325.
  • 10Hierholzer C,Harbrecht B G,Billiar T R,et al.Hypoxia-inducible factor-1 activation and cyclo-oxygenase-2 induction are early reperfusion-independent inflammatory events in hemorrhagic shock[J].Arch Orthop Trauma Surg,2001,121(4):219-222.

共引文献1381

同被引文献61

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1379
  • 2张友才,陈金霞,陈永平,邓长生.上皮型钙黏素基因启动子甲基化与胃肠腺癌的关系及意义[J].山东医药,2007,47(10):16-17. 被引量:6
  • 3Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005 [J].CA Cancer J Clin, 2005,55 (1) : 10-30.
  • 4Sica GL,Choi IH,Zhu G,et al. B7-H4,a molecule of the B7 family negatively regulates T cell immunity[J]. Immunity,2003,18(6): 849-861.
  • 5Salceda S, TangT, Kmet M, et al. The immunomodulatory protein BT-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation [J]. Exp Cell Res,2005,306(1): 128-141.
  • 6Krambeck AE, Thompson RH, Dong H, et al. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival[J]. Proc Natl Acad Sci USA, 2006,103 (27) : 10391-10396.
  • 7Sun Y,Wang Y,Zhao J, et al. B7-H3 and B7-H4 expression in non-small-cell lung cancer[J]. Lung Cancer, 2006,53 (2) : 143-151.
  • 8Fleming ID, Phillips JL, Menck HR, et al. The National Cancer Data Base report on recent hospital cancer program progress toward complete American Joint Committee on Cancer/ TNM staging [J ]. Cancer, 1997, 80 (12) : 2305- 2310.
  • 9Wittekind C, Compton CC, Greene FL, et al. TNM residual tumor classification revisited[J]. Cancer, 2002,4 (9) : 2511- 2516.
  • 10Beier D, Hau P, Proescholdt M, et al. CD133(+) and CD133 (-) glioblastoma- derived cancer stem cells show differential growth characteristics and molecular profiles [J].Cancer Res, 2007,67(9) : 4010-4015.

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部